BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4584035)

  • 1. Historical development and future promise of the nitrosoureas as anticancer agents.
    Schabel FM
    Cancer Chemother Rep 3; 1973 May; 4(3):3-6. PubMed ID: 4584035
    [No Abstract]   [Full Text] [Related]  

  • 2. Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.
    Wheeler GP; Bowdon BJ; Grimsley JA; Lloyd HH
    Cancer Res; 1974 Jan; 34(1):194-200. PubMed ID: 4809457
    [No Abstract]   [Full Text] [Related]  

  • 3. Early history and development of the nitrosoureas.
    Schepartz SA
    Cancer Treat Rep; 1976 Jun; 60(6):647-9. PubMed ID: 782693
    [No Abstract]   [Full Text] [Related]  

  • 4. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP; Schein PS
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical aspects of drug combinations.
    Brockman RW
    Cancer Chemother Rep 2; 1974 Mar; 4(1):115-29. PubMed ID: 4135108
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S; Ogawa M; Sakurai Y
    Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.
    Johnston TP; Montgomery JA
    Cancer Treat Rep; 1986 Jan; 70(1):13-30. PubMed ID: 2935250
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
    [No Abstract]   [Full Text] [Related]  

  • 9. An overview of the status of the nitrosoureas in other tumors.
    Carter SK
    Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination therapy: some concepts and results.
    Skipper HE
    Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure-activity relationships: nitrosoureas.
    Johnston TP
    Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
    [No Abstract]   [Full Text] [Related]  

  • 12. Formulation of three nitrosoureas for intravenous use.
    Davignon JP; Yang KW; Wood HB; Cradock JC
    Cancer Chemother Rep 3; 1973 May; 4(3):7-11. PubMed ID: 4201309
    [No Abstract]   [Full Text] [Related]  

  • 13. [Foundations of the therapy of inoperable malignomas and hemoblastoses].
    Stacher A
    Wien Med Wochenschr; 1976 Jan; 126(5):51-4. PubMed ID: 948909
    [No Abstract]   [Full Text] [Related]  

  • 14. [Research results and prospects in the field of experimental leukemia chemotherapy].
    Kozinets GI; Khomchenovskiĭ EI; Reshchikov VP; Khanykova OK; Egorov LV
    Probl Gematol Pereliv Krovi; 1979 Jan; 24(1):3-7. PubMed ID: 368760
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224).
    Gosse C; Atassi G; Letourneux Y; Ardouin P; Gouyette A; Fournier JP; Roger P
    Anticancer Res; 1988; 8(6):1419-22. PubMed ID: 3218975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The biochemical mechanisms of drug resistance to N-alkyl-N-nitrosoureas and derivatives of cis-dichlorodiammineplatinum].
    Gorbacheva LB
    Vopr Onkol; 1995; 41(2):50-1. PubMed ID: 7483435
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in the biochemical pharmacology of selected alkylating agents.
    Wheeler GP
    Transplant Proc; 1973 Sep; 5(3):1167-70. PubMed ID: 4738047
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides.
    Gugova R; Topakbashian V; Lozeva S; Dimov S; Golovinsky E
    Drugs Exp Clin Res; 1997; 23(2):71-5. PubMed ID: 9309382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nitrosoureas--thoughts for the future.
    Carter SK; Wasserman TH
    Cancer Treat Rep; 1976 Jun; 60(6):807-11. PubMed ID: 954014
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
    Hansch C; Leo A; Schmidt C; Jow PY; Montgomery JA
    J Med Chem; 1980 Oct; 23(10):1095-101. PubMed ID: 7420354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.